Patents by Inventor Alexander Krasnitz

Alexander Krasnitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DETERMINING A PROBABILISTIC DIAGNOSIS OF CANCER BY ANALYSIS OF GENOMIC COPY NUMBER VARIATIONS
    Publication number: 20210103642
    Abstract: The present invention provides methods and compositions related to genomic profiling, and in particular, to assigning probabilistic measure of clinical outcome for a patient having a disease or a tumor using segmented genomic profiles such as those produced by representational oligonucleotide microarray analysis (ROMA).
    Type: Application
    Filed: April 23, 2018
    Publication date: April 8, 2021
    Inventors: Michael H. Wigler, James Hicks, Alexander Krasnitz, Anders Zetterberg
  • DETERMINING A PROBABILISTIC DIAGNOSIS OF CANCER BY ANALYSIS OF GENOMIC COPY NUMBER VARIATIONS
    Publication number: 20190325113
    Abstract: The present invention provides methods and compositions related to genomic profiling, and in particular, to assigning probabilistic measure of clinical outcome for a patient having a disease or a tumor using segmented genomic profiles such as those produced by representational oligonucleotide microarray analysis (ROMA).
    Type: Application
    Filed: April 23, 2018
    Publication date: October 24, 2019
    Inventors: Michael H. Wigler, James Hicks, Alexander Krasnitz, Anders Zetterberg
  • Genetic markers indicative of a cancer patient response to trastuzumab (herceptin)
    Patent number: 9677139
    Abstract: The invention relates to the fields of therapeutics and identifying candidates for therapy, in particular to a method of identifying candidates for trastuzumab (Herceptin®) therapy in a patient presenting with breast cancer based on the presence or absence of specific genetic markers in a tumor sample from said patient.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: June 13, 2017
    Assignee: COLD SPRING HARBOR LABORATORY
    Inventors: James Hicks, Alexander Krasnitz
  • GENETIC MARKERS INDICATIVE OF A CANCER PATIENT RESPONSE TO TRASTUZUMAB (HERCEPTIN)
    Publication number: 20160340735
    Abstract: The invention relates to the fields of therapeutics and identifying candidates for therapy, in particular to a method of identifying candidates for trastuzumab (Herceptin®) therapy in a patient presenting with breast cancer based on the presence or absence of specific genetic markers in a tumor sample from said patient.
    Type: Application
    Filed: June 7, 2012
    Publication date: November 24, 2016
    Inventors: James Hicks, Alexander Krasnitz
  • DETERMINING A PROBABILISTIC DIAGNOSIS OF CANCER BY ANALYSIS OF GENOMIC COPY NUMBER VARIATIONS
    Publication number: 20140025307
    Abstract: The present invention provides methods and compositions related to genomic profiling, and in particular, to assigning probabilistic measure of clinical outcome for a patient having a disease or a tumor using segmented genomic profiles such as those produced by representational oligonucleotide microarray analysis (ROMA).
    Type: Application
    Filed: July 16, 2013
    Publication date: January 23, 2014
    Applicant: COLD SPRING HARBOR LABORATORY
    Inventors: Michael H. Wigler, James B. Hicks, Alexander Krasnitz, Anders P. Zetterberg
  • GENETIC MARKERS INDICATIVE OF A CANCER PATIENT RESPONSE TO TRASTUZUMAB (HERCEPTIN)
    Publication number: 20120328607
    Abstract: The invention relates to the fields of therapeutics and identifying candidates for therapy, in particular to a method of identifying candidates for trastuzumab (Herceptin®) therapy in a patient presenting with breast cancer based on the presence or absence of specific genetic markers in a tumor sample from said patient.
    Type: Application
    Filed: June 7, 2012
    Publication date: December 27, 2012
    Inventors: James Hicks, Alexander Krasnitz
  • Method for designing a therapeutic regimen based on probabilistic diagnosis for genetic diseases by analysis of copy number variations
    Publication number: 20100227768
    Abstract: The present invention provides methods and compositions related to genomic profiling, and in particular, to assigning probabilistic measure of clinical outcome for a patient having a disease or a tumor using segmented genomic profiles such as those produced by representational oligonucleotide microarray analysis (ROMA).
    Type: Application
    Filed: December 14, 2006
    Publication date: September 9, 2010
    Inventors: Michael H. Wigler, James B. Hicks, Alexander Krasnitz, Anders P. Zettenberg